Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics.

Advances in therapy·2026
Same author

Short- and long-term changes in renal function following percutaneous cryoablation: a comparison of endophytic versus exophytic renal tumors.

Journal of vascular and interventional radiology : JVIR·2026
Same author

AZD8630/AMG 104, an inhaled anti-thymic stromal lymphopoietin antibody fragment, for moderate-to-severe asthma: Phase 1 randomized controlled trial.

The Journal of allergy and clinical immunology·2026
Same author

INSIGHTS Asthma Pragmatic Registry - A Pragmatic Approach to High-Validity Real-World Evidence for Asthma.

Pragmatic and observational research·2025
Same author

Efficacy and safety of sequential transarterial embolization and cryoablation of renal masses greater than 3 cm.

Urologic oncology·2025
Same author

Robust workflow for diaphyseal cortical bone thickness calculation.

Journal of biomechanics·2025

Related Experiment Video

Updated: Jun 7, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K

Predicting Asthma Exacerbations Using Machine Learning Models.

Gianluca Turcatel1, Yi Xiao1, Scott Caveney2

  • 1Digital Health and Innovation, Amgen Inc., Thousand Oaks, CA, USA.

Advances in Therapy
|November 18, 2024
PubMed
Summary

Machine learning accurately predicts asthma exacerbations using electronic health records. The study identified known risk factors and novel protective factors for asthma attacks, aiding in patient risk stratification.

Keywords:
AsthmaElectronic health recordsExacerbationsMachine learningPhysician-diagnosed asthmaReal-world predictionXGBoost

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.4K

Related Experiment Videos

Last Updated: Jun 7, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.4K

Area of Science:

  • Utilizes machine learning (ML) and electronic health records (EHR) for predictive analytics in respiratory medicine.
  • Applies advanced algorithms like Extreme Gradient Boosting (XGBoost), Long Short-Term Memory (LSTM), and Transformers for disease prediction.

Background:

  • Existing clinical, functional, and biomarker data offer limited accuracy for predicting asthma exacerbations in real-world settings.
  • Need for advanced prognostic approaches to improve asthma management and decision-making.
  • Machine learning (ML) offers a powerful tool for identifying patterns in large EHR datasets to forecast future disease events.

Purpose of the Study:

  • To train and fine-tune ML algorithms for the accurate, real-world prediction of asthma exacerbations.
  • To identify clinical factors associated with both increased and decreased risk of asthma exacerbations.

Main Methods:

  • Retrieved data from the Optum Panther EHR database (2016-2023) for adult patients with asthma.
  • Defined asthma exacerbations as emergency, urgent care, or inpatient visits with systemic corticosteroid use.
  • Trained and tested XGBoost, LSTM, and Transformer models on clinical data from a 6-month baseline period to predict exacerbations in the subsequent 6 months.
  • Employed SHAP (SHapley Additive exPlanations) for model interpretability.

Main Results:

  • Out of 1,331,934 asthma patients, 1.2% experienced at least one exacerbation.
  • XGBoost demonstrated the highest predictive performance (AUC = 0.964).
  • Key predictors of exacerbations included prior exacerbation history, prednisone use, high-dose albuterol, and elevated troponin I.
  • Reduced exacerbation probability was linked to inhaled albuterol, vitamins, aspirin, statins, furosemide, and influenza vaccination.

Conclusions:

  • The ML model confirmed known risk factors for asthma exacerbations and identified novel factors associated with reduced risk.
  • Findings provide hypothesis-generating insights for asthma patient risk stratification.
  • Highlights the potential and limitations of ML models in clinical decision support for asthma management.